NCT00505089View on ClinicalTrials.gov

Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

May 31, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

ACZ885

DRUG

ACZ885

DRUG

ACZ885

DRUG

ACZ885

Trial Locations (9)

Unknown

Novartis Investigative site, Antwerp

Novartis Investigator Site, Liège

Novartis Investigative site, Berlin

Novartis Investigator Site, Berlin

Novartis Investigator Site, Hanover

Novartis Investigator Site, Leipzig

Novartis investigative site, Leiden

Novartis Investigative Site, Grodzisk Mazowiecki

Novartis Investigator Site, Poznan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY